Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins

Successful vaccine efforts countering the COVID-19 pandemic are centralized around the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein as viral antigen and have greatly reduced the morbidity and mortality associated with COVID-19. Since the start of this pandemic, SARS...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 13; p. 1025500
Main Authors O’Donnell, Kyle L., Gourdine, Tylisha, Fletcher, Paige, Clancy, Chad S., Marzi, Andrea
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 24.10.2022
Subjects
Online AccessGet full text

Cover

Loading…